Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ayala Pharmaceuticals, Inc.

0.0333
+0.0000
Volume:62.00
Turnover:2.10
Market Cap:1.42M
PE:0.00
High:0.0333
Open:0.0333
Low:0.0333
Close:0.0333
Loading ...

Company Profile

Company Name:
Ayala Pharmaceuticals, Inc.
Exchange:
EXPERT
Establishment Date:
- -
Employees:
21
Office Location:
1007 North Orange Street,4th Floor,Wilmington,Delaware,United States
Zip Code:
19802
Fax:
- -
Introduction:
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. It is also developing proprietary Lm-based antigen delivery products for patients suffering from common cancers. The company's lead candidates under development are AL102, which targets the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat various tumors, including desmoid tumors; and ADXS-504, a Lm-based therapy for early-stage prostate cancer. Ayala Pharmaceuticals, Inc. was founded in 2017 and is based in Monmouth Junction, New Jersey.